Literature DB >> 33966385

Development of Nonfouling Zwitterionic Copolymerized Peptides Based on Glutamic Acid and Lysine Dimers for Adjustable Enzymatic Degradation.

Yumeng Guo1, Liangbo Xu1, Weifeng Lin1, Shengfu Chen1,2.   

Abstract

Nonspecific protein adsorption-resistant materials, the so-called nonfouling materials, are crucial biomaterials in biomedical applications. Up-to-date, little attention was paid to the biodegradability of these materials. In this work, nonfouling zwitterionic copolymerized peptides composed of the N-l-glumatyl-l-lysine dimer (EK) and δ-l-lysinyl-l-glutamic acid dimer (E-K, glutamic acid with the lysine side chain) at various ratios were synthesized to investigate the enzymatic degradation rate. Two types of proteases (trypsin and alkaline protease), which represent a site-specific and less site-specific cleavage protease, respectively, were used to demonstrate the adjustable degradability by tracking the molecular weight (Mw) at different digestion times. Results showed that higher compositions of the E-K dimer lead to slower degradation rates by both proteases and larger fragments after 120 min digestion. With the composition of the E-K dimer over 50%, the degradation of copolymerized peptides by both proteases becomes very slow. This indicated that the bulky lysinyl side chain on E-K can alter the enzymolysis process for adjusting the enzymatic degradability of the newly synthesized zwitterionic copolymerized peptides, which could be promising candidates for biomedical applications in vivo.

Entities:  

Year:  2021        PMID: 33966385     DOI: 10.1021/acs.langmuir.1c00021

Source DB:  PubMed          Journal:  Langmuir        ISSN: 0743-7463            Impact factor:   3.882


  2 in total

Review 1.  Recent Advances in Zwitterionic Hydrogels: Preparation, Property, and Biomedical Application.

Authors:  Sihang Liu; Jingyi Tang; Fangqin Ji; Weifeng Lin; Shengfu Chen
Journal:  Gels       Date:  2022-01-07

2.  A pH-Responsive Zwitterionic Polyurethane Prodrug as Drug Delivery System for Enhanced Cancer Therapy.

Authors:  Qian He; Rui Yan; Wanting Hou; Haibo Wang; Yali Tian
Journal:  Molecules       Date:  2021-08-31       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.